Determination of Myloid Antigen Expression on Childhood Acute Lymphoblastic Leukaemia Cells: Discrepancies Using Different Monoclonal Antibody Clones

References

• Mirro J., Zipf T. F., Pui C. H., Kitchingman G., Williams D., Melvin S., Murphy S. B., Stass S. Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance. Blood 1985; 66: 1115–1123
   PubMed Web of Science ®Google Scholar
• Sobol R. E., Mick R., Royston I., Davey F. R., Ellison R. R., Newman R., Cuttner J., Griffin J. D., Collins H., Nelson D. A. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. New England Journal of Medicine 1987; 316: 1111–1117
   PubMed Web of Science ®Google Scholar
• Pui C. H., Behm F. G., Singh B., Rivera G. K., Schell M. J., Roberts W. M., Crist W. M., Mirro J., Jr. Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood 1990; 75: 198–202
   PubMed Web of Science ®Google Scholar
• Urbano-Ispizua A., Matutes E., Villamor N., Ribera J. M., Feliu E., Montserrat E., Granena A., Vives-Corrons J. L., Rozman C. Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia. British Journal of Haematology 1990; 75: 202–207
   PubMed Web of Science ®Google Scholar
• Guyotat D., Campos L., Shi Z. H., Charrin C., Treille D., Magaud J. P., Fiere D. Myeloid surface antigen expression in adult acute lymphoblastic leukemia. Leukemia 1990; 4: 664–666
   PubMed Web of Science ®Google Scholar
• Childs C. C., Hirsch-Ginsberg C., Walters R. S., Andersson B. S., Reuben J., Trujillo J. M., Cork A., Stass S. A., Freireich E. J., Zipf T. F. Myeloid surface antigen-positive acute lymphoblastic leukemia (My+ ALL): immunophenotypic, ultrastructural, cytogenetic, and molecular characteristics. Leukemia 1989; 3: 777–783
   PubMed Web of Science ®Google Scholar
• Pui C H, Rubnitz J E, Hancock M L, Downing J R, Raimondi S C, Rivera G K, Sandlund J T, Ribeiro R C, Head D R, Relling M V, Evans W E, Behm FG. Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia. J Clin Oncol Dec, 1998; 16(12)3768–73
   PubMed Web of Science ®Google Scholar
• Kurec A. S., Belair P., Stefanu C., Barrett D. M., Dubowy R. L., Davey F. R. Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia. Cancer 1991; 67: 3081–3086
   PubMed Web of Science ®Google Scholar
• Wiersma S. R., Ortega J., Sobel E., Weinberg K. I. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. New England Journal of Medicine 1991; 324: 800–808
   PubMed Web of Science ®Google Scholar
• Cantu-Rajnoldi A., Putti C., Saitta M., Granchi D., Foa R., Schiro R., Castagni M., Valeggio C., Jankovic M., Miniero R., et al. Co-expression of myeloid antigens in childhood acute lymphoblastic leukaemia: relationship with the stage of differentiation and clinical significance. British Journal of Haematology 1991; 79: 40–43
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Sather H. N., Gaynon P. S., Arthur D. C., Trigg M. E., Tubergen D. G., Nachman J., Steinherz P. G., Sensel M. G., Reaman G. H. Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 1997; 90: 28–35
   PubMed Web of Science ®Google Scholar
• Putti M. C., Rondelli R., Cocito M. G., Arico M., Sainati L., Conter V, Guglielmi C., Cantu-Rajnoldi A., Consolini R., Pession A., Zanesco L., Masera G., Biondi A., Basso G. Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88–91 studies. Blood 1998; 92: 795–801
   PubMed Web of Science ®Google Scholar
• Baruchel A., Cayuela J. M., Ballerini P., Landman-Parker J., Cezard V., Firat H., Haddad E., Auclerc M. F., Valensi F., Cayre Y. E., Macintyre E. A., Sigaux F. The majority of myeloid-antigen-positive (My+) childhood B-cell precursor acute lymphoblastic leukaemias express TEL-AML1 fusion transcripts. British Journal of Haematology 1997; 99: 101–106
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. British Journal of Haematology 1981; 47: 553–561
   PubMed Web of Science ®Google Scholar
• Baruchel A., Leverger G., Schaison G. Use of immunophenotype as part of the prognostic stratification for childhood ALL in the FRALLE 93 protocol. Leukemia & Lymphoma 1994; 13: 91–93
   PubMed Web of Science ®Google Scholar
• Drexler H. G., Thiel E., Ludwig W. D. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia 1991; 5: 637–645
   PubMed Web of Science ®Google Scholar
• Lauria F, Raspadori D., Martinelli G., Rondelli D., Ventura M. A., Farabegoli P., Tosi P., Testoni N., Visani G., Zaccaria A., et al. Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications. British Journal of Haematology 1994; 87: 286–292
   PubMed Web of Science ®Google Scholar
• Boucheix C., David B., Sebban C., Racadot E., Bene M. C., Bernard A., Campos L., Jouault H., Sigaux F, Lepage E., et al. Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic Leukemia. Blood 1994; 84: 1603–1612
   PubMed Web of Science ®Google Scholar
• Borowitz M. J., Shuster J., Carroll A. J., Nash M., Look A. T., Camitta B., Mahoney D., Lauer S. J., Pullen D. J. Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study. Blood 1997; 89: 3960–3966
   PubMed Web of Science ®Google Scholar
• Hayashi Y., Pui C. H., Behm F. G., Fuchs A. H., Raimondi S. C., Kitchingman G. R., Mirro J., Jr, Williams D. L. 14q32 translocations are associated with mixed-lineage expression in childhood acute leukemia. Blood 1990; 76: 150–156
   PubMed Web of Science ®Google Scholar
• Borkhardt A., Cazzaniga G., Viehmann S., Valsecchi M. G., Ludwig W. D., Burci L., Mangioni S., Schrappe M., Riehm H., Lampert F., Basso G., Masera G., Harbott J., Biondi A. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Munster Study Group. Blood 1997; 90: 571–577
   PubMed Web of Science ®Google Scholar